211 related articles for article (PubMed ID: 31930677)
1. RNF152 positively regulates TLR/IL-1R signaling by enhancing MyD88 oligomerization.
Xiong MG; Xu ZS; Li YH; Wang SY; Wang YY; Ran Y
EMBO Rep; 2020 Mar; 21(3):e48860. PubMed ID: 31930677
[TBL] [Abstract][Full Text] [Related]
2. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F
Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
[TBL] [Abstract][Full Text] [Related]
4. IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).
Chen Z; Su L; Xu Q; Katz J; Michalek SM; Fan M; Feng X; Zhang P
J Biol Chem; 2015 Dec; 290(50):30163-74. PubMed ID: 26483549
[TBL] [Abstract][Full Text] [Related]
5. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
[TBL] [Abstract][Full Text] [Related]
6. Pellino 2 is critical for Toll-like receptor/interleukin-1 receptor (TLR/IL-1R)-mediated post-transcriptional control.
Kim TW; Yu M; Zhou H; Cui W; Wang J; DiCorleto P; Fox P; Xiao H; Li X
J Biol Chem; 2012 Jul; 287(30):25686-95. PubMed ID: 22669975
[TBL] [Abstract][Full Text] [Related]
7. Postoperative ileus involves interleukin-1 receptor signaling in enteric glia.
Stoffels B; Hupa KJ; Snoek SA; van Bree S; Stein K; Schwandt T; Vilz TO; Lysson M; Veer CV; Kummer MP; Hornung V; Kalff JC; de Jonge WJ; Wehner S
Gastroenterology; 2014 Jan; 146(1):176-87.e1. PubMed ID: 24067878
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
Gohda J; Matsumura T; Inoue J
J Immunol; 2004 Sep; 173(5):2913-7. PubMed ID: 15322147
[TBL] [Abstract][Full Text] [Related]
9. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.
Janssens S; Burns K; Tschopp J; Beyaert R
Curr Biol; 2002 Mar; 12(6):467-71. PubMed ID: 11909531
[TBL] [Abstract][Full Text] [Related]
10. TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase.
Wang W; Huang X; Xin HB; Fu M; Xue A; Wu ZH
J Biol Chem; 2015 May; 290(21):13372-85. PubMed ID: 25861989
[TBL] [Abstract][Full Text] [Related]
11. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo.
Bellocchio S; Montagnoli C; Bozza S; Gaziano R; Rossi G; Mambula SS; Vecchi A; Mantovani A; Levitz SM; Romani L
J Immunol; 2004 Mar; 172(5):3059-69. PubMed ID: 14978111
[TBL] [Abstract][Full Text] [Related]
12. Contrasting roles of the IL-1 and IL-18 receptors in MyD88-dependent contact hypersensitivity.
Klekotka PA; Yang L; Yokoyama WM
J Invest Dermatol; 2010 Jan; 130(1):184-91. PubMed ID: 19657352
[TBL] [Abstract][Full Text] [Related]
13. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
Akira S; Hoshino K
J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
[TBL] [Abstract][Full Text] [Related]
14. TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88.
Ohnishi H; Tochio H; Kato Z; Kawamoto N; Kimura T; Kubota K; Yamamoto T; Funasaka T; Nakano H; Wong RW; Shirakawa M; Kondo N
PLoS One; 2012; 7(6):e38423. PubMed ID: 22685567
[TBL] [Abstract][Full Text] [Related]
15. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus.
Miller LS; O'Connell RM; Gutierrez MA; Pietras EM; Shahangian A; Gross CE; Thirumala A; Cheung AL; Cheng G; Modlin RL
Immunity; 2006 Jan; 24(1):79-91. PubMed ID: 16413925
[TBL] [Abstract][Full Text] [Related]
16. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity.
Su SB; Silver PB; Grajewski RS; Agarwal RK; Tang J; Chan CC; Caspi RR
J Immunol; 2005 Nov; 175(10):6303-10. PubMed ID: 16272281
[TBL] [Abstract][Full Text] [Related]
17. SARM modulates MyD88-mediated TLR activation through BB-loop dependent TIR-TIR interactions.
Carlsson E; Ding JL; Byrne B
Biochim Biophys Acta; 2016 Feb; 1863(2):244-53. PubMed ID: 26592460
[TBL] [Abstract][Full Text] [Related]
18. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
[TBL] [Abstract][Full Text] [Related]
19. The role of intermediary domain of MyD88 in cell activation and therapeutic inhibition of TLRs.
Avbelj M; Horvat S; Jerala R
J Immunol; 2011 Sep; 187(5):2394-404. PubMed ID: 21804016
[TBL] [Abstract][Full Text] [Related]
20. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
